{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T12:54:37Z","timestamp":1793019277003,"version":"4.5.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,3]]},"DOI":"10.7759\/cureus.98386","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T16:34:17Z","timestamp":1764779657000},"source":"Crossref","is-referenced-by-count":1,"title":["7-Hydroxymitragynine and Nicotine Pouch Withdrawal Syndrome: A Case Report"],"prefix":"10.7759","author":[{"given":"Akshay","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beena S","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudhakar","family":"Pemminati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"United Nations Office on Drugs and Crime. World drug report 2024. (2024). Accessed: 11\/15\/2025: https:\/\/www.unodc.org\/unodc\/en\/data-and-analysis\/world-drug-report-2024.html."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.2001","article-title":"Clinical pharmacology of the dietary supplement kratom (Mitragyna speciosa)","volume":"62","author":"Hartley C 2nd","year":"2022","unstructured":"Hartley C 2nd, Bulloch M, Penzak SR. Clinical pharmacology of the dietary supplement kratom (Mitragyna speciosa). J Clin Pharmacol. 2022, 62:577-93. 10.1002\/jcph.2001","journal-title":"J Clin Pharmacol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2017.08.026","article-title":"The medicinal chemistry and neuropharmacology of kratom: a preliminary discussion of a promising medicinal plant and analysis of its potential for abuse","volume":"134","author":"Kruegel AC","year":"2018","unstructured":"Kruegel AC, Grundmann O. The medicinal chemistry and neuropharmacology of kratom: a preliminary discussion of a promising medicinal plant and analysis of its potential for abuse. Neuropharmacology. 2018, 134:108-20. 10.1016\/j.neuropharm.2017.08.026","journal-title":"Neuropharmacology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2903\/j.efsa.2022.e200415","article-title":"Assessment of the possible health risks associated with the consumption of botanical preparations of Mitragyna speciosa (kratom)","volume":"20","author":"Papadi G","year":"2022","unstructured":"Papadi G, Bakhiya N, Ildico Hirsch-Ernst K. Assessment of the possible health risks associated with the consumption of botanical preparations of Mitragyna speciosa (kratom). EFSA J. 2022, 20:e200415. 10.2903\/j.efsa.2022.e200415","journal-title":"EFSA J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.12788\/acp.0012","article-title":"Kratom: a growing substance of abuse in the United States","volume":"32","author":"Demick DS","year":"2020","unstructured":"Demick DS, Lee TT, Summers AT, El-Mallakh RS. Kratom: a growing substance of abuse in the United States. Ann Clin Psychiatry. 2020, 32:275-80. 10.12788\/acp.0012","journal-title":"Ann Clin Psychiatry"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2024.114913","article-title":"Beneficial and adverse health effects of kratom (Mitragyna speciosa): a critical review of the literature","volume":"192","author":"Heywood J","year":"2024","unstructured":"Heywood J, Smallets S, Paustenbach D. Beneficial and adverse health effects of kratom (Mitragyna speciosa): a critical review of the literature. Food Chem Toxicol. 2024, 192:114913. 10.1016\/j.fct.2024.114913","journal-title":"Food Chem Toxicol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2174\/1389450121666200719011653","article-title":"Kratom dependence and treatment options: a comprehensive review of the literature","volume":"21","author":"Bin Abdullah MF","year":"2020","unstructured":"Bin Abdullah MF. Kratom dependence and treatment options: a comprehensive review of the literature. Curr Drug Targets. 2020, 21:1566-79. 10.2174\/1389450121666200719011653","journal-title":"Curr Drug Targets"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.psc.2022.04.002","article-title":"Kratom: substance of abuse or therapeutic plant?","volume":"45","author":"Gorelick DA","year":"2022","unstructured":"Gorelick DA. Kratom: substance of abuse or therapeutic plant?. Psychiatr Clin North Am. 2022, 45:415-30. 10.1016\/j.psc.2022.04.002","journal-title":"Psychiatr Clin North Am"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2014.03.017","article-title":"Kratom (Mitragyna speciosa) dependence, withdrawal symptoms and craving in regular users","volume":"139","author":"Singh D","year":"2014","unstructured":"Singh D, M\u00fcller CP, Vicknasingam BK. Kratom (Mitragyna speciosa) dependence, withdrawal symptoms and craving in regular users. Drug Alcohol Depend. 2014, 139:132-7. 10.1016\/j.drugalcdep.2014.03.017","journal-title":"Drug Alcohol Depend"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2024.111329","article-title":"Kratom addiction per DSM-5 SUD criteria, and kratom physical dependence: insights from dosing amount versus frequency","volume":"260","author":"Rogers JM","year":"2024","unstructured":"Rogers JM, Weiss ST, Epstein DH, Grundmann O, Hill K, Smith KE. Kratom addiction per DSM-5 SUD criteria, and kratom physical dependence: insights from dosing amount versus frequency. Drug Alcohol Depend. 2024, 260:111329. 10.1016\/j.drugalcdep.2024.111329","journal-title":"Drug Alcohol Depend"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp161035","article-title":"Pharmacologic and clinical assessment of kratom","volume":"75","author":"White CM","year":"2018","unstructured":"White CM. Pharmacologic and clinical assessment of kratom. Am J Health Syst Pharm. 2018, 75:261-7. 10.2146\/ajhp161035","journal-title":"Am J Health Syst Pharm"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/zxz221","article-title":"Pharmacologic and clinical assessment of kratom: an update","volume":"76","author":"White CM","year":"2019","unstructured":"White CM. Pharmacologic and clinical assessment of kratom: an update. Am J Health Syst Pharm. 2019, 76:1915-25. 10.1093\/ajhp\/zxz221","journal-title":"Am J Health Syst Pharm"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.122.001005","article-title":"Translating kratom-drug interactions: from bedside to bench and back","volume":"51","author":"Tanna RS","year":"2023","unstructured":"Tanna RS, Cech NB, Oberlies NH, Rettie AE, Thummel KE, Paine MF. Translating kratom-drug interactions: from bedside to bench and back. Drug Metab Dispos. 2023, 51:923-35. 10.1124\/dmd.122.001005","journal-title":"Drug Metab Dispos"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2017.00062","article-title":"Biochemical benefits, diagnosis, and clinical risks evaluation of kratom","volume":"8","author":"Fluyau D","year":"2017","unstructured":"Fluyau D, Revadigar N. Biochemical benefits, diagnosis, and clinical risks evaluation of kratom. Front Psychiatry. 2017, 8:62. 10.3389\/fpsyt.2017.00062","journal-title":"Front Psychiatry"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2018.1562133","article-title":"Kratom withdrawal: a systematic review with case series","volume":"51","author":"Stanciu CN","year":"2019","unstructured":"Stanciu CN, Gnanasegaram SA, Ahmed S, Penders T. Kratom withdrawal: a systematic review with case series. J Psychoactive Drugs. 2019, 51:12-8. 10.1080\/02791072.2018.1562133","journal-title":"J Psychoactive Drugs"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1037\/pha0000755","article-title":"A comprehensive review on oral nicotine pouches: available scientific evidence and future research needs","volume":"33","author":"Zamarripa CA","year":"2025","unstructured":"Zamarripa CA, Dowd AN, Elder HJ, et al.. A comprehensive review on oral nicotine pouches: available scientific evidence and future research needs. Exp Clin Psychopharmacol. 2025, 33:123-32. 10.1037\/pha0000755","journal-title":"Exp Clin Psychopharmacol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-024-01524-1","article-title":"Controversies in assessment, diagnosis, and treatment of kratom use disorder","volume":"26","author":"Smith KE","year":"2024","unstructured":"Smith KE, Epstein DH, Weiss ST. Controversies in assessment, diagnosis, and treatment of kratom use disorder. Curr Psychiatry Rep. 2024, 26:487-96. 10.1007\/s11920-024-01524-1","journal-title":"Curr Psychiatry Rep"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/01.MLR.0000093487.78664.3C","article-title":"The Patient Health Questionnaire-2: validity of a two-item depression screener","volume":"41","author":"Kroenke K","year":"2003","unstructured":"Kroenke K, Spitzer RL, Williams JB. The Patient Health Questionnaire-2: validity of a two-item depression screener. Med Care. 2003, 41:1284-92. 10.1097\/01.MLR.0000093487.78664.3C","journal-title":"Med Care"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke K","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001, 16:606-13. 10.1046\/j.1525-1497.2001.016009606.x","journal-title":"J Gen Intern Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/417361-7-hydroxymitragynine-and-nicotine-pouch-withdrawal-syndrome-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T16:34:18Z","timestamp":1764779658000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/417361-7-hydroxymitragynine-and-nicotine-pouch-withdrawal-syndrome-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,3]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.98386","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,3]]}}}